The Official CORMEDIX (CRMD)thread (run up to FDA approval has begun )

[Tug life]

GET OUT!!!!!!

 

[CBalla]

lets see what kmph does AH tomorrow

 

[Tug life]

They got a CRL for manufacturing issue they need eto work this out before they get approved. I'm selling most of my shares and getting back in later trading opens back a 9 a.m.

 

[ORDER_66]

What happened now????

 

[Skooby]

CRMD down $8.00 in premarket. WTF!?

 

[GunRanger]

Didnt notice the premarket drop and robinhood gave no notification



Too late to sell any. Gonna wait and buy a little more maybe. The main positive is that there was nothing wrong with the data. I dont see why the manufacturing should influence the passing of the drug but whatever

 

[L68]

Smh

 

[Skooby]

They got a CRL for manufacturing issue they need eto work this out before they get approved. I'm selling most of my shares and getting back in later trading opens back a 9 a.m.

Too late for me. Didn't see it in time.

I held on to all of mine. Never sold.

I wonder how long it'll take the manufacturing issues to fix.

 

[CBalla]

WaynD (@WaynD01) | Stocktwits

if ur looking for a new bio play watch kmph tomorrow

 

[Tug life]

Too late for me. Didn't see it in time.

I held on to all of mine. Never sold.

I wonder how long it'll take the manufacturing issues to fix.

After reading the PR I think I overreacted. They said it's nothing wrong with the drug and it will be approved under LPAD for hemodialysis patients once they clear up the manufacturing issue. I think the approval date will be sometime this summer now. I sold some in hope of buying close to my $5 average but the stock seems to have recovered well. It's basically where we were st before the big run up. I'm getting back in fully loading on dips

 

[Tug life]

WaynD (@WaynD01) | Stocktwits

if ur looking for a new bio play watch kmph tomorrow

Just copped some options. How you feel about this one?

 

[Ratmaster]

I guess we are all just holding and waiting until the summer? I assume the manufacturing issue will have worked out and things will get approved. Till then, I’ll just load up.

 

[KING WILL]

SAN DIEGO, Nov. 1, 2019 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) announced today new data demonstrating that suppression of NR2F6 using patent-pending compounds developed by the Company results in selective inhibition of new blood vessels under conditions associated with cancer and wet macular degeneration. The data, which was obtained using human umbilical vein endothelial cells (HUVEC), indicates that NR2F6 may have a larger biological role than originally suspected.' data-reactid="12">SAN DIEGO, Nov. 1, 2019 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) announced today new data demonstrating that suppression of NR2F6 using patent-pending compounds developed by the Company results in selective inhibition of new blood vessels under conditions associated with cancer and wet macular degeneration. The data, which was obtained using human umbilical vein endothelial cells (HUVEC), indicates that NR2F6 may have a larger biological role than originally suspected.

Regen BioPharma, Inc. has been utilizing NR2F6 as a target for immune modulation and cancer stem cells. To the Company's knowledge, this is the first indication to date that NR2F6 is involved in the formation of new blood vessels.

Thomas Ichim, PhD, co-inventor of the patent and consultant to the Company. "In our experiments, we observed that inhibition of NR2F6 selectively blocked multiplication of blood vessel cells that were stimulated with Vascular Endothelial Growth Factor (VEGF). Since VEGF is associated with disease conditions, it is possible that our approach possesses some degree of specificity in blocking pathological but not healthy formation of new blood vessels. New blood vessels suggests that this approach may not suppress healthy blood vessels which are primarily formed independently of VEGF."' data-reactid="14">"New blood vessels are typically not formed in an adult except in conditions such as cancer (in which the tumor cells require a new blood supply) or in wet macular degeneration; a condition in which new blood vessels result in impairment of vision," said Thomas Ichim, PhD, co-inventor of the patent and consultant to the Company. "In our experiments, we observed that inhibition of NR2F6 selectively blocked multiplication of blood vessel cells that were stimulated with Vascular Endothelial Growth Factor (VEGF). Since VEGF is associated with disease conditions, it is possible that our approach possesses some degree of specificity in blocking pathological but not healthy formation of new blood vessels. New blood vessels suggests that this approach may not suppress healthy blood vessels which are primarily formed independently of VEGF."

$2.8 Billion in 20181) for cancer and Lucentis (Sales $1.9 Billion in 20182).' data-reactid="15">Drugs which target VEGF as a means of suppressing pathological blood vessel formation include Avastin (Sales $2.8 Billion in 20181) for cancer and Lucentis (Sales $1.9 Billion in 20182).

David Koos. "We believe this coupled with our current small molecule therapies as a quality additional approach to treating cancer."" data-reactid="16">"What this data demonstrates is a potential mechanism to kill cancer cells without the toxicity associated with conventional treatments," noted the Company's Chairman & CEO David Koos. "We believe this coupled with our current small molecule therapies as a quality additional approach to treating cancer."






Yahoo is now part of Verizon Media​

Any get in on rgbp?

Regen BioPharma About To Become A Major Pharma Player - Insider Financial

 

[OrdaineD]

Is it too late ? It went up like 800% already.

Any get in on rgbp?

Regen BioPharma About To Become A Major Pharma Player - Insider Financial

 

[KING WILL]

Is it too late ? It went up like 800% already.

Folks are saying Monday will. Be a huge too